1. Home /
  2. Biotechnology company /
  3. Caprion Biosciences


Category

General Information

Locality: Montreal, Quebec

Address: 201, avenue Président-Kennedy H2X 3Y7 Montreal, QC, Canada

Website: caprion.com

Likes: 117

Reviews

Add review



Facebook Blog

Caprion Biosciences 19.11.2020

Looking for a global partner for clinical immune profiling? Talk with our experts in cell-mediated immunity for guidance on the right assay and platform. Contact us for more info: https://tinyurl.com/y22a3uqv #flowcytometry #HistoGeneX #CROlaboratory #CaprionBioSci... #flowcytometry #HistoGeneX #CROlaboratory #CaprionBioSci

Caprion Biosciences 12.11.2020

Register to our upcoming #WEBINAR to learn about ELISpot and intracellular cytokine staining (ICS) by flow cytometry. Our speaker will provide key elements to consider when choosing one of these methods to investigate vaccine efficacy. Reserve your spot today: https://bit.ly/2It6PtZ ICS and ELISpot for the Study of Cell Response: Choosing the Optimal Method in Immuno-Oncology or COVID-19 Vaccination Trials... Speaker: Philippe Pouliot, PhD, Director Development Team (Immunology), Caprion Biosciences Inc. Date and Time: October 29, 2020 | 11am EDT | 4pm BST #flowcytometry #immunooncology #covid19 #vaccines #CROlaboratory #CaprionBioSci #HistoGeneX

Caprion Biosciences 27.10.2020

Have you missed our #WEBINAR co-sponsored with WIRB-Copernicus Group on the importance of assessing T-cell response during the development of COVID-19 vaccines? Watch it now: https://bit.ly/3iRTQyl #covid19 #vaccines #CROlaboratory #CaprionBioSci #HistoGeneX

Caprion Biosciences 07.10.2020

WEBINAR: Should Assessing T-Cell Response Be an Essential Part of COVID-19 Vaccine Development? October 1st, 2020 | 1-2pm ET Register now: https://bit.ly/33MTVxG Register to hear what KOLs have to say about the importance of assessing T-cell response during the development of COVID-19 vaccines.

Caprion Biosciences 21.09.2020

Caprion-HistoGeneX and Viroclinics-DDL announce a strategic partnership to offer integrated, complementary services to advance infectious disease research and COVID-19 therapeutic development. For more information: https://bit.ly/3ikm9Wx